Platelet activation and antiplatelet therapy in sepsis: a narrative review

Y Wang, Y Ouyang, B Liu, X Ma, R Ding - Thrombosis Research, 2018 - Elsevier
Platelet activation plays an important role in the development of sepsis. During sepsis,
platelet activation leads to endothelial cell injury and promotes neutrophil extracellular trap …

[HTML][HTML] Progress in the development of antiplatelet agents: Focus on the targeted molecular pathway from bench to clinic

Q Xiang, X Pang, Z Liu, G Yang, W Tao, Q Pei… - Pharmacology & …, 2019 - Elsevier
Antiplatelet drugs serve as a first-line antithrombotic therapy for the management of acute
ischemic events and the prevention of secondary complications in vascular diseases …

Eptifibatide, an older therapeutic peptide with new indications: from clinical pharmacology to everyday clinical practice

G Tonin, J Klen - International Journal of Molecular Sciences, 2023 - mdpi.com
Therapeutic peptides are oligomers or short polymers of amino acids used for various
medical purposes. Peptide-based treatments have evolved considerably due to new …

A new paradigm shift in antithrombotic therapy

A Pudusseri, R Shameem… - Frontiers in …, 2013 - frontiersin.org
Decades after the introduction of oral anti-coagulants namely the vitamin K antagonist (VKA)
Warfarin and antiplatelet agents such as Aspirin and Plavix, new classes of direct, small …

An Efficient Access to 5‐(1, 2, 3‐Triazol‐1‐yl) isoxazoles–Previously Unknown Structural Type of Triazole‐isoxazole Hybrid Molecule

DA Vasilenko, SE Dronov, YK Grishin… - Asian Journal of …, 2022 - Wiley Online Library
Since isoxazole and triazole have significant applications in pharmaceutical chemistry, the
synthesis of hybrid isoxazole‐triazole molecules has attracted great attention. In the present …

A case of pulmonary hemorrhage due to drug-induced pneumonitis secondary to ticagrelor therapy

TJ Whitmore, JP O'Shea, D Starac, MG Edwards… - Chest, 2014 - Elsevier
We report a case of significant pulmonary hemorrhage developing shortly after commencing
ticagrelor and aspirin therapy and requiring coronary artery bypass grafting to safely cease …

Application of Quantitative NMR (qHNMR) towards Establishment of Pharmaceutical Reference Standard; A Case of a Ticagrelor Process Impurity

S Bhavaraju, SG Sreerama, D Taylor… - Chemical and …, 2022 - jstage.jst.go.jp
Quantitative proton NMR (qHNMR) methodology was employed for the stoichiometric (free
base and the corresponding counterion) assessment of a ticagrelor process impurity, also …

[HTML][HTML] Short-term efficacy of ticagrelor in acute ST-segment elevation myocardial infarction patients undergoing an emergency percutaneous coronary intervention

B Cao, F Qu, X Liu, C Gao, Q Fu, C Jiang, P Wei… - Aging (Albany …, 2019 - ncbi.nlm.nih.gov
In total, 97 acute ST-segment elevation myocardial infarction (STEMI) patients who received
an emergency percutaneous coronary intervention (PCI) were enrolled and divided into a …

Assaying the antiplatelet ticagrelor by validated UV spectrophotometric method with performance equivalent to HPLC

S Sales Oliveira, A da Silva Bitencourt… - Current …, 2017 - ingentaconnect.com
Objective: An analytical assay with focus on UV spectrophotometric method was proposed
as alternative for the analysis of the antiplatelet ticagrelor. Method: Method performance was …

[HTML][HTML] Bioequivalence study of ticagrelor in normal, healthy Indian subjects under fasting conditions: A randomized, blinded, crossover study

TP Pradeep, RK Gattu, AK Naralasetty, S Nadig… - Heart India, 2023 - journals.lww.com
Objectives: The objectives of this study were to evaluate the bioequivalence and safety
profiles of the test drug and reference drug of 90 mg ticagrelor tablets under fasting …